FACTA HEALTH, INC. v. PHARMADENT, LLC

CourtDistrict Court, D. New Jersey
DecidedMay 11, 2022
Docket2:20-cv-09631
StatusUnknown

This text of FACTA HEALTH, INC. v. PHARMADENT, LLC (FACTA HEALTH, INC. v. PHARMADENT, LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
FACTA HEALTH, INC. v. PHARMADENT, LLC, (D.N.J. 2022).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

: FACTA HEALTH, INC. et al, : : Civil Action No. 20-09631 (SRC) Plaintiffs, : : v. : OPINION : PHARMADENT, LLC et al, : : Defendants. : : :

CHESLER, District Judge

This matter comes before the Court upon the motion filed by Plaintiffs Facta Health, Inc. (“Facta”), Frank Cozzarelli, Robert Mangone, Paul Kapp, Robert Laudadio, and Gotta Guy, Inc. (collectively, “Plaintiffs”) seeking an Order “[i]n aid of litigant’s rights enforcing the Court’s Order with respect to the Court’s order and Opinion of October 8, 2020” and “[d]irecting the Arbitrators in the proper means and manner necessary to comply with the Order Directing Arbitration.” The Court’s October 8, 2020 Order, which evaluated a Patent Purchase Agreement into which Facta and Defendant Pharmadent, LLC (“Pharmadent”) entered on or about October 16, 2018 (the “Agreement”), required that the Parties undertake the alternative dispute resolution procedure set forth in the Agreement which culminates, if necessary, in final and binding arbitration.1 It is apparent that the Parties are now past the point at which arbitration was demanded

1 The Court further stayed litigation in this action pending the resolution of those efforts. and arbitration is scheduled to proceed imminently.2 Defendants Pharmadent, Alan Wickenhauser, and Stephen Peipert (collectively, “Defendants”) oppose the motion. Plaintiffs’ objections appear to amount to two main concerns, including that: (i) Defendants have not provided Plaintiffs proper notice of certain counterclaims which

Defendants pursue; and (ii) the Parties are improperly subject to a four-day arbitration. In making their motion, Plaintiffs ignore the fact that the Court simply is not a referee which can police the manner in which an arbitrator conducts an arbitration. See Lloyd v. HOVENSA, LLC., 369 F.3d 263, 270 (3d Cir. 2004) (“The legislative scheme of the FAA thus reflects a policy decision that, if a district court determines that arbitration of a claim is called for, the judicial system’s interference with the arbitral process should end unless and until there is a final award.”); Travelers Ins. Co. v. Davis, 490 F.2d 536, 541–42 (3d Cir. 1974) (“Under the Federal Arbitration Act . . . a district court does not have the power to review an interlocutory ruling by an arbitration panel . . . .”). If, as Plaintiffs contend, the arbitration proceeds in a manner such as to violate their rights, they are free to challenge the final award in the manner set forth by

the Federal Arbitration Act. See 9 U.S.C. § 10(a) (establishing grounds by which an arbitration award may be vacated). For these reasons, Plaintiffs’ motion will be denied. An appropriate Order will issue.

/s/ Stanley R. Chesler____ STANLEY R. CHESLER United States District Judge

Date: May 11, 2022

2 As of May 5, 2022, the arbitration was scheduled to begin on June 7, 2022. (Dfts. Opp. at 1.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
FACTA HEALTH, INC. v. PHARMADENT, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/facta-health-inc-v-pharmadent-llc-njd-2022.